INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC., THE GENERAL HOSPITAL CORPORATION FILES APPLICATION FOR "GENOMIC PROFILING OF CELLS TO MONITOR MINIMUM RESIDUAL DISEASE"

GENEVA, May 13 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, Massachusetts 02215-5450), THE GENERAL HOSPITAL CORPORATION (55 Fruit StreetBoston, Massachusetts 02114) filed a patent application (PCT/US2025/053913) for "GENOMIC PROFILING OF CELLS TO MONITOR MINIMUM RESIDUAL DISEASE" on Nov 04, 2025. With publication no. WO/2026/097062, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GHOBRIAL, Irene (450 Brookline AvenueBoston, Massachusetts 02215-5450), ALBERGE, Jean-Baptiste (450 Brookline AvenueBoston...